Diseases, Conditions, Syndromes

Adding a P2Y12 inhibitor does not improve outcomes in COVID-19

(HealthDay)—The addition of a P2Y12 inhibitor to anticoagulant therapy does not improve organ support-free days among non-critically ill patients hospitalized for COVID-19, according to a study published in the Jan. 18 ...

page 4 from 23